Covid Vaccine Stocks slip back to lowest point - a return of just 61% overall for all stocks. Every stock in the index lost ground this week except Immunity Bio.
COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Saturday, 19 February 2022
Total Return tumbles back to just 61% overall
Friday, 18 February 2022
Broad-based sell-off to end the week - 24 stocks dropped.
Another broad-based sell-off with 24 stocks dropping and only three gaining.
The overall average was a significant loss of 3.2%.
The biggest loser was Generex falling 20%. Tonix dropped 8% and PDS dropped 7%.
Thursday, 17 February 2022
Unanimous Sell-off Down 5.5% on average overall
Tuesday, 15 February 2022
Big broad-based gains for Covid Vaccine Stocks - Immunity Bio jumps 22%
Rocketing upwards on February 15. A real strong broad-based move upwards lead by Immunity Bio which moved up 22%. There were fully 24 winners and only three losers today.
The next strongest gainers were Novavax and Vaxart with 9% gains.
Vir, Ocugen and VBI all picked up 7%.
Monday, 14 February 2022
Heavy selling to start the week - Big Three hit hard.
Heavy selling to start the week. Overall there was a loss of 3.5%. There were 22 stocks who lost ground and five that gained.
The big three took the biggest hit. Moderna fell just under 12%, Novavax fell 11% and BioNTech fell 10%. Arcturus fell 7%.
CureVac, Vir, Sorrento and Tonix fell 6%.
OncoSec and iBio picked up 5%.
Saturday, 12 February 2022
Covid Vaccine Stocks move moderately higher.
Covid Vaccine Stocks bounce off the lows of January with total returns edging up to 72%.
PDS jumps by 117% in total returns and into third spot.
Friday, 11 February 2022
Week finishes with a 2.3% drop
Stocks close the week slipping another 2.3%. There were no double digit losses but only six that gained ground with 21 losers.
Adaptive lead on the downside with a loss of 8%. Inovio lost 6%. Emergent lead on the upside with a gain of 5%.
Tuesday, 8 February 2022
Small loss of 1.8% overall - Novavax stumbles 12%
Stocks edged downward, falling 1.8% overall with 17 losers and nine winners.
Novavax lead on the way down with a 12%. BioNTech fell 7% and TNXP fell 6%.
IMV lead on the upside picking up just under 5%.
Monday, 7 February 2022
Generex jumps by one half
Generex delivers one of the biggest gains in the Covid era with a 51% leap.
This outsized gain generated a 3.6% overall gain. There were 22 winners today and five losers.
IMV picked up just under 8%, and Novavax is nearing a breakthrough of $100, closing at $94.80 after gaining 6%.
Friday, 4 February 2022
Moderate move up with a 1.9% gain - 22 stocks gain and 5 lose.
That makes two positive days in a row. Today it was a gain of 1.9% on average overall.
IMV lead the way up with a double digit gain with a 10% pick up.
PDS picked up 6% whilte iBio, Inovio and Adaptive all picked up 5%.
Thursday, 3 February 2022
Moderately hard move to the downside - 3.4% Loss
Another quite hard blow with 3.4% loss overall.
There were no double digit losses but fully 12 stocks dropped 5% or more.
Only Generex and Vir gained with the other 25 losing ground.
iBio continued its down hill slalom leading the way down the hill, losing 7%. PDS dropped just under 7%.
CureVac seems to be headed to 0 with another 6% loss. Immunity Bio, IMV and Inovio all lost over 6%.
Wednesday, 2 February 2022
Blood-letting resumes after brief reprieve
After a reprieve of a few days and a couple really good days, the blood-letting resumed this Ground Hog Day.....
The overall average was a loss of 3.8%, notwithstanding and amazing gain by the seriously lagging Generex which picked up almost 16% today.
There were no double digit losses, but a ton of big single digit losses, lead by VBI, Sorrento, Heat Bio and Inovio, all with losses of over 7%.
Tuesday, 1 February 2022
Modest move upwards with a gain of 1.9% overall. Ocugen up 9%.
A modestly positive day with a gain of 1.9% overall. 21 stocks gained ground with 5 losing.
The biggest gainer was Ocugen with a pick up of 9%. The biggest loser was IBio with a loss of just over 5%.
Monday, 31 January 2022
Explosion upwards. One of biggest days of all time with an 8.6% overall gain. Fully 10 stocks picked up more than 10%
What a day! Total Explosion upwards! This has building for a while. The overall gain was 8.6%. Every single stock moved up except Generex slipped 5% to a new low.
There are literally 10 stocks with more than 10% gains. The biggest gainer was hard bitten Arcturus which jumped over 17%. Sorrento picked up just under 17%.
Ocugen and PDS picked up 14%. Novavax had a 13% gain.
Saturday, 29 January 2022
Overall return slips further to 61%. BioNTech moves into 3rd
Top Ten continue to sag, but worst of selling seemed to stall with a strong Friday. BioNTech moves up to 3rd overall a strong 42% pick up in today return, far outpacing all others. PDS dropped 39% and into 4th overall.
Sorrento falls out of the top ten, replaced by Vaxart.
Friday, 28 January 2022
Huge Bounce Back day - up 4.8% overall
Huge Bounce Back Day! Overall bounce was 4.8% on average with 25 stocks moving up and only two going down.
Novavax finally rebounded up 14%. Altimmune and PDS Bio went up 10% to arrest a horrific downdraft. Vir jumped up just under 9%.
Thursday, 27 January 2022
Total Wash Out. One of the worst days ever. Average loss of 5.5% on average. Sorrento and Tonix falls more than 10%
A Total washout. Red Sea. Warren Buffet would never invest in these turds.
One of the worst days ever. Hard to believe it could be this bad for these stocks.
Imagine losing 5.5% on average after the hell this month has been already.
Sorrento and Tonix had double digit losses. 12 stocks had losses of over 5%. This day sucked.
Friday, 21 January 2022
Dance the Limbo! CureVac down 14% - 4.5% sell off
How low can this go? After a pause with just painful losses, we move back to ugly downdraft losses.
Covid Vaccine stocks slumped 4.5% overall with full 23 dropping and only four picking up ground.
CureVac is racing to a penny stock with another 14% buckling to lead on the way down.
NanoViricides took a 10% hit, Sorrento dipped 9%, GeoVax and Ocugen fell 8%, Tonix dipped 7% and Novavax, BioNTech and PDS dropped 6%.
Thursday, 20 January 2022
Pain continues - 2.7% losses on average overall
No double digit losses, but another painful 2.7% loss overall. Fully seven stocks lost 5% or more.
Only EBS and Dynavax gained.
Tonix and IBio lead on the way down with losses in the 6.5% range.
Wednesday, 19 January 2022
Another 2.4% loss overall. OncoSec hit with a double digit loss
Another 2.4% loss overall as brutality continues. OncoSec let on the downside with another 10% hit. It has had a not bad couple of weeks after a disastrous year.
Moderna and Ocugen fell 7%, while Novavax fell 6%, Vir tumbled 5% and with BioNTech not far behind fall 4.5%.
There were only two gainers and three others that did nothing -- a major win in this hellscape.
Subscribe to:
Posts (Atom)